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SA casual reader might be tempted to skip over the article
by Apitz and colleagues in this issue, dismissing it as irrel-
evant to clinical practice. The title is also somewhat off-
putting because ‘‘aortic constriction’’ evokes only bad
images in the mind of any cardiac surgeon. In fact, how-
ever, this elegant yet traditional cardiac physiology exper-
iment shows that chronic aortic constriction not only
improves right ventricular (RV) function in the setting of
chronic RV pressure overload but also leads to less malad-
aptive RV remodeling. This article does inform on highly
relevant themes, such as ventricle-ventricle interaction,
timing of RV remodeling, and the molecular signature ofRV profibrotic reactions. It may also open the door to
a very untraditional way of managing the remodeled RV.
The problem of the hypertrophied yet not decompensated
RV is typically solved by an early repair of the anatomy,
such as early repair of tetralogy of Fallot for example.
No one would consider ‘‘banding’’ the aorta to allow for
reverse RV remodeling. What, however, about the thick, fi-
brotic RV in an older patient with unrepaired pulmonary
stenosis? Should we consider, akin to pulmonary artery
banding and left ventricular training in an older patient
with transposition of the great arteries, a period of aortic
afterload increase to reposition the septum and maybe re-
verse some of the myocardial profibrotic signaling? What
about managing the failing postoperative RV? In the set-
ting of good left ventricular function, and in the absence
of any current drugs that can directly increase RV contrac-
tility, systemic afterload increase by pharmacologic means
may in fact have a role to play.
At a time when therapeutic answers are being sought
mostly in genetics and tissue engineering, this study re-
minds us that physiologic research remains an essential
and vital tool.diovascular Surgery c Volume 144, Number 6 1501
